Compound Detail
CHEMBL229845
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL229845 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HAQKDTSRYFEZHG-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
234.7
MW (Da)
1.48
ALogP
4
HBA
0
HBD
57.1
PSA (Ų)
0.44
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 1 meas. best 6.71
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 6.71 | 6.71 | 196.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | Ki | = | 196.0 | nM | 6.71 | Displacement of [3H]flumazenil from bovine brain cortex GABAA/Bz receptor | 17306981 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17306981 | 10.1016/j.bmc.2007.01.053 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine